Peptide LocalCompare price, evidence & access
Search /Compare vendors
Locations/United Kingdom/MariTide
Purchase and availability checkMariTide in the United Kingdom

Can you buy MariTide in the United Kingdom?

This page does not establish a legitimate retail purchase from the compound name or an online listing alone. MariTide is an investigational clinical program.

Direct answers →Open official records →Open the interactive status check
Evidence lane
Investigational clinical program
Destination
United Kingdom
Source records
3
Reviewed
24 July 2026
ByPeptide Local Editorial DeskUpdated 24 July 2026How we review
Direct answers

What this exact search can and cannot establish.

Each answer stays attached to the compound identity and destination records. This is a verification guide, not medical or legal advice, a seller recommendation, or proof of availability.

01

Can you buy MariTide in the United Kingdom?

This page does not establish a legitimate retail purchase from the compound name or an online listing alone. MariTide is an investigational clinical program. No seller listing in the United Kingdom can inherit the sponsor’s clinical identity, trial evidence, or regulatory status. Check any exact product and supplier claim in the destination records below. Before acting on an offer, match the exact product, authorization, seller identity, and supply route in the official records below.

02

Which official records should be checked for MariTide in United Kingdom?

Resolve the exact identity of MariTide through Phase 2 dose-ranging study - NCT05669599 from ClinicalTrials.gov. Then search Search licensed medicine product information from Medicines and Healthcare products Regulatory Agency for the destination product record and Search the register from General Pharmaceutical Council for the seller, establishment, or supply route in United Kingdom. A match in one record does not replace the other two checks.

03

Does an online listing prove MariTide is authorized or available in United Kingdom?

No. A page using the name MariTide, local currency, a domestic delivery claim, or a familiar package image is only a lead. This is an investigational program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For United Kingdom, the exact product, presentation, seller identity, current record status, and claimed supply route must resolve through the official sources on this page.

Live trial footprint

MariTide clinical trials in United Kingdom

4 study records currently list 73 locations in this country, including 47 locations individually marked Recruiting.

Registry update: 24 July 2026
Study records
4
Listed locations
73
Recruiting locations
47
Records with local recruiting sites
2
NCT07037433
Study-wide statusRecruiting

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Listed locations
28
Recruiting locations
28
Registry update
2026-07-24
NCT07037459
Study-wide statusRecruiting

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

Listed locations
19
Recruiting locations
19
Registry update
2026-07-02
NCT06858878
Study-wide statusActive, not recruiting

Efficacy and Safety of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight

Listed locations
11
Recruiting locations
0
Registry update
2025-12-31
NCT06858839
Study-wide statusActive, not recruiting

Evaluation of Maridebart Cafraglutide in Adult Participants Without Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight

Listed locations
15
Recruiting locations
0
Registry update
2025-10-20
Continue the exact comparison

Related country and compound records.

Compare another tracked name in United Kingdom, or keep MariTide fixed and change the destination within Europe. The identity, product, and seller checks remain separate.

Continue the exact comparison

MariTide in Europe

MariTide across 42 countries
Identity before availability

A name alone cannot establish a local verdict.

MariTide is an investigational clinical program. No seller listing in the United Kingdom can inherit the sponsor’s clinical identity, trial evidence, or regulatory status. Check any exact product and supplier claim in the destination records below.

Primary identity source: Phase 2 dose-ranging study - NCT05669599 / ClinicalTrials.gov ↗
Three-record verification path

Identity. Product. Seller or supply.

A credible result must keep these separate. The official links answer different questions and should be checked in sequence.

Phase 2 dose-ranging study - NCT05669599

Phase 2 dose-ranging study - NCT05669599 is maintained by ClinicalTrials.gov. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.

Open Phase 2 dose-ranging study - NCT05669599 ↗

Search licensed medicine product information

Search licensed medicine product information is maintained by Medicines and Healthcare products Regulatory Agency. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.

Open Search licensed medicine product information ↗

Search the register

Search the register is maintained by General Pharmaceutical Council. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.

Open Search the register ↗
United Kingdom / Country guide

United Kingdom market context.

A website can look clinical without being a registered pharmacy. The GPhC register is the relevant check for Great Britain pharmacy premises and professionals.

  • The GPhC provides a public register for pharmacy professionals and premises in Great Britain.
  • MHRA publishes safety information and enforcement updates for medicines and medical products.
  • A UK price table will launch only after the seller class and delivery claims are verified.
Destination checklist

Repeat the country checks before comparing any offer.

The country guide supplies the local verification sequence. It does not convert an online listing into an authorized product or verified seller.

01

Check the register

Confirm pharmacy premises and professional details in the official GPhC register.

02

Separate categories

Do not treat a laboratory chemical listing as a substitute for a prescribed medicine.

03

Record the evidence

Keep the seller, batch document, currency, VAT, delivery limit, and date checked together.

Primary evidence

Audit every source used by this page.

Open the live record and confirm its current status. A linked source begins the verification process; it does not mean Peptide Local authenticated a product or seller.

01
Phase 2 dose-ranging study - NCT05669599ClinicalTrials.gov
02
Search licensed medicine product informationMedicines and Healthcare products Regulatory Agency
03
Search the registerGeneral Pharmaceutical Council
04
Medicines safety guidanceMHRA
05
MariTide study search in United KingdomClinicalTrials.gov
06
NCT07037433: Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or ObesityClinicalTrials.gov
07
NCT07037459: Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and ObesityClinicalTrials.gov
08
NCT06858878: Efficacy and Safety of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus Who Have Obesity or Are OverweightClinicalTrials.gov
09
NCT06858839: Evaluation of Maridebart Cafraglutide in Adult Participants Without Type 2 Diabetes Mellitus Who Have Obesity or Are OverweightClinicalTrials.gov
Audit and handoff

Keep the exact record attached.